Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer’s disease

Abstract

Background Although convolutional neural networks (CNNs) achieve high diagnostic accuracy for detecting Alzheimer’s disease (AD) dementia based on magnetic resonance imaging (MRI) scans, they are not yet applied in clinical routine. One important reason for this is a lack of model comprehensibility. Recently developed visualization methods for deriving CNN relevance maps may help to fill this gap as they allow the visualization of key input image features that drive the decision of the model. We investigated whether models with higher accuracy also rely more on discriminative brain regions predefined by prior knowledge. Methods We trained a CNN for the detection of AD in N = 663 T1-weighted MRI scans of patients with dementia and amnestic mild cognitive impairment (MCI) and verified the accuracy of the models via cross-validation and in three independent samples including in total N = 1655 cases. We evaluated the association of relevance scores and hippocampus volume to validate the clinical utility of this approach. To improve model comprehensibility, we implemented an interactive visualization of 3D CNN relevance maps, thereby allowing intuitive model inspection. Results Across the three independent datasets, group separation showed high accuracy for AD dementia versus controls (AUC ≥ 0.91) and moderate accuracy for amnestic MCI versus controls (AUC ≈ 0.74). Relevance maps indicated that hippocampal atrophy was considered the most informative factor for AD detection, with additional contributions from atrophy in other cortical and subcortical regions. Relevance scores within the hippocampus were highly correlated with hippocampal volumes (Pearson’s r ≈ −0.86, p < 0.001). Conclusion The relevance maps highlighted atrophy in regions that we had hypothesized a priori. This strengthens the comprehensibility of the CNN models, which were trained in a purely data-driven manner based on the scans and diagnosis labels. The high hippocampus relevance scores as well as the high performance achieved in independent samples support the validity of the CNN models in the detection of AD-related MRI abnormalities. The presented data-driven and hypothesis-free CNN modeling approach might provide a useful tool to automatically derive discriminative features for complex diagnostic tasks where clear clinical criteria are still missing, for instance for the differential diagnosis between various types of dementia.

Deep learning identifies brain structures that predict cognition and explain heterogeneity in cognitive aging

“…S1 , S2 , S3 ), design choices for LIME such as sampling method can influence the approximation. Validating these results with other model interpretation methods such as SHAP ( Lundberg and Lee, 2017 ), DeepLIFT ( Avanti et al, 2017 ), and layer-wise relevance propagation ( Dyrba et al, 2021 ; Montavon et al, 2019 ) is important.…”

Automated Evaluation of Conventional Clock-Drawing Test Using Deep Neural Network: Potential as a Mass Screening Tool to Detect Individuals With Cognitive Decline

“…Next, we apply gradient-weighted class activation mapping (Grad-CAM) ( 10 ) to visualize the features on which the DNN model focuses within CDT images to make a judgment. Alternative method such as layer-wise relevance propagation ( 11 ) was not used here because it was not available in the R keras toolchain. Output from the last convolutional layer as marked by a star in Supplementary Figure S1C was used for the analysis ( https://github.com/rstudio/keras/issues/182 ).…”

Structural and functional MRI data differentially predict chronological age and behavioral memory performance

“…Machine learning-based techniques such as support vector machine (SVM) classification and regression provide promising approaches to differentiate normal from pathological neurocognitive aging. They have been employed to predict chronological age from structural magnetic resonance imaging (MRI; Cole et al, 2017, 2018), to estimate brain age (Bashyam et al, 2020; Habes et al, 2021) or to distinguish health from disease (Dyrba et al, 2021; Eitel et al, 2021).…”